Alcidion acquires Silverlink Software

Alcidion Group Ltd. (ASX:ALC) has acquired Silverlink PCS Software Limited.

Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. The group integrates with EMR providers and assists doctors and nurses, covering functions such as streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety and productivity amongst clinical staff through messaging applications, and data capture and interpretation.

Silverlink is one of the largest and last remaining specialist patient administration system (PAS) providers servicing the UK NHS market. It is recognized as being a flexible, cost-effective PAS that can easily integrate with other clinical systems to support a specialist modular system approach, enabling the benefits of a full electronic patient record (EPR/EMR) without single supplier lock-in.

Oaklins’ team in Australia acted as M&A corporate advisor to Alcidion Group Ltd. on the acquisition of Silverlink Software.

Servicio

M&A buy-side

Partes

“This is the second acquisition Oaklins has advised Alcidion on over the past 18 months. It has played a key role in the successful completion of both transactions. Oaklins consistently provided professional and commercial advice over the course of the transaction, which enabled us to navigate any deal issues that arose. Oaklins and its experienced team continue to show a deep understanding of the industry and remain a key strategic advisor to our company.”

Kate Quirke

Group Managing Director, Alcidion Group Limited

Contáctese con el equipo de la transacción

Scott McInnes

Director Ejecutivo

Melbourne, Australia
Oaklins Henslow

Ver perfil Contáctenos

Sebastian Bell

Director

Sydney, Australia
Oaklins Henslow

Ver perfil Contáctenos

Transacciones relacionadas

Medicija has acquired Saulės Šeimos Medicinos Centras

Salud

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Aprenda más

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Salud

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Aprenda más

IXICO has completed a fundraising

Salud

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Aprenda más